Japan electroceuticals Market: Global Industry Growth, Market Size, Market Share and Forecast 2019- 2025

Japan electroceuticals market is expected to grow at a CAGR of 7.6% during the forecast period. Japan is contributing significantly to the electroceuticals market. Geriatric population is one of the major concerns for the Japanese government and other healthcare institution. Out of total 126 million population, about 27% population of the country was above 65 years in 2017. It is forecast that the population will reduce to 123 million in 2023 and geriatric population is forecast to be higher as compared to 2017. Additionally, life expectancy of the people in Japan is the highest globally. The incidence of heart stroke occurrence in geriatric population is relatively high as compared to young population. As per the Institute for Health Metrics and Evaluation, in 2017, around 0.2 million incidences of ischemic heart disease occurred in Japan. The prevalence of Ischemic heart disease in 2013 was 3.5 million peoples that have increased to 3.7 million in 2017.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/japan-electroceuticals-market

The other major factor that provides significant growth to the market is product approval in the country. Companies such as Sorin CRM SAS, Century Medical, Inc., Medtronic Japan Company Limited, and St. Jude Medical Japan Company Limited, have received their product approval from the government regulatory bodies in the FY 2018 and FY 2019. Neurostimulators, pacemakers, and defibrillators are the major electroceuticals approved by the government, however, only a single new cochlear implant approval has been observed during the tracking period. The results of foreign clinical studies were also submitted to evaluate the efficacy and safety of the electroceuticals in the country for various electroceuticals.

LivaNova had received Japan's Ministry of Health, Labour & Welfare approval for Perceval suture less aortic heart valve to treat aortic valve disease that enables to provide patients and clinicians in Japan with a new option for aortic heart valve replacement. Additionally, the company had received the US FDA 510(k) clearance of the MEMO4D semi-rigid mitral annuloplasty ring and confirmed the first implantation of the device.

Browse the full report description Japan electroceuticals Market at https://www.omrglobal.com/industry-reports/japan-electroceuticals-market

Japan Electroceuticals Market-Segmentation

By Product and By its Application

o Cardioverter Defibrillators and Cardiac Pacemaker
o Arrhythmias
o Deep Brain Stimulators
o Parkinson's Disease
o Depression
o Spinal Cord Stimulators
o Failed Back Syndrome
o Ischemia
o Vagus Nerve Stimulators
o Epilepsy
o Cochlear Implants
o Sensorineural Hearing Loss
o Others (Sacral Nerve Stimulators, Transcutaneous Electrical Nerve Stimulators)
o Urinary Incontinence
o Treatment-Resistant Depression

By End-Users
o Hospitals and Clinics
o Research Institutes

Company Profiles
o Abbott Laboratories Inc.
o Boston Scientific Corp.
o Century Medical, Inc.
o Demant A/S
o Edwards Lifesciences Corp.
o Getinge AB
o GlaxoSmithKline PLC
o Livanova PLC
o Medtronic PLC
o Renishaw PLC

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.